Skip to main content
. 2023 Aug 22;13:13664. doi: 10.1038/s41598-023-40508-8

Table 2.

Comparing whether the criteria for introducing oxygen therapy are met or not.

Meet the criteria for introducing oxygen therapy
Yes No p-value
Patients 88 (59.9) 59 (40.1)
Patient characteristics at initiation of oxygenation therapy
Age, year 72.5 (67.0–78.8) 71.0 (66.0–76.0) 0.338
Sex, male 72 (81.8) 45 (76.3) 0.414
Body mass index, kg/m2 22.2 (19.8–24.9) 22.2 (19.6–25.0) 0.828
Smoking history 65 (73.9) 47 (79.7) 0.438
Duration of IPF, month 46.5 (24.0–74.3) 45 (26–66) 0.539
Past history of acute exacerbation 19 (21.6) 9 (15.3) 0.396
Surgical lung biopsy 19 (21.6) 45 (76.3) 0.841
FVC, % predicted 60.7 (49.9–72.3) 62.0 (55.3–72.3) 0.513
DLCO, %predicted 38.9 (32.0–48.0) 40.0 (29.5–52.2) 0.902
Pulmonary hypertension 53 (60.2) 0 (0)  < 0.001
Resting hypoxaemia (SpO2 < 88%) 22 (25.0) 0 (0)  < 0.001
PaCO2 breathing air, mmHg 40.6 (37.6–45.5) 41.0 (37.7–45.0) 0.652
6MWT distance, m 270 (171–385) 298 (200–452) 0.215
Minimum SpO2 on 6MWT, % 80.0 (70.0–86.0) 83.5 (73.0–88.0) 0.068
CAT 20.0 (15.0–26.0) 21.0 (16.0–28.0) 0.264
mMRC scale 0.283
 0 1 (1.1) 2 (3.4)
 1 9 (10.2) 9 (15.3)
 2 31 (53.2) 22 (37.3)
 3 39 (44.3) 17 (28.8)
 4 8 (9.1) 9 (15.3)
GAP stage 0.141
 I 12 (13.6) 11 (18.6)
 II 71 (80.7) 48 (81.4)
 III 5 (5.7) 0 (0)
Outcome
Median survival time, days 450 (259–641) 662 (420–903) 0.116
Death 67 46 0.636
 Chronic respiratory failure 34 (50.7) 25 (54.3)
 Acute exacerbation 19 (28.4) 12 (26.1)
 Lung cancer 3 (4.4) 2 (4.3)
 Others 11 (16.4) 7 (15.2)
Lung transplantation 1 0 N/A

Data are presented as median (IQR) or n (%).

IQR, interquartile range; FVC, forced vital capacity; DLCO, diffusion capacity of the lung for carbon monoxide; SpO2, oxygen saturation of peripheral blood; PaCO2, arterial partial pressure of carbon dioxide; 6MWT, six-minute walk test; CAT, COPD assessment test; mMRC scale, modified Medical Research Council Dyspnea scale; GAP, gender age and physiology; N/A, not applicable.